Fig. 1 · Structure
Documents & Downloads
Moguisteine
Antitussive Agent
Moguisteine (BBR-2173) is an antitussive agent that operates through non-opioid pathways, lacking significant affinity for opiate receptors. It is primarily utilized in research to investigate cough reflex modulation and to explore alternative therapeutic strategies for cough management without the side effects associated with opioids. Moguisteine serves as a valuable tool for studying the mechanisms underlying cough and developing novel antitussive therapies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 119637-67-1 |
| Applications | Antitussive Agent |
| Formula | C16H21NO5S |
| Molecular Weight | 339.41 |
| Synonyms | BBR-2173 |
| SMILES | COC1=CC=CC=C1OCC2N(C(CC(OCC)=O)=O)CCS2 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.